Harm reduction, human rights, and access to information on safer abortion

被引:32
作者
Erdman, Joanna N. [1 ]
机构
[1] Yale Univ, Sch Law, Informat Soc Project, New Haven, CT 06511 USA
关键词
Harm reduction; Human rights; Information; Medical abortion; Misoprostol; Safer use; Unsafe abortion; CARE;
D O I
10.1016/j.ijgo.2012.04.002
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A harm reduction and human rights approach, grounded in the principles of neutrality, humanism, and pragmatism, supports women's access to information on the safer self- use of misoprostol in diverse legal settings. Neutrality refers to a focus on the risks and harms of abortion rather than its legal or moral status. Humanism refers to the entitlement of all women to care and concern for their lives and health, to be treated with respect, worth, and dignity, and to the empowerment of women to participate in decision-making and political action. Pragmatism accepts the historical reality that women will engage in unsafe abortion, including self-induction, while addressing factors that render them vulnerable to this reality, and requires assessment of interventions to reduce abortion-related harms on evidence of their real rather than intended effect. Criminal law reform is a necessary conclusion to a harm reduction and human rights approach. (C) 2012 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:83 / 86
页数:4
相关论文
共 23 条
[1]  
Ahman E., 2011, Unsafe abortion: global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008, V6th
[2]  
[Anonymous], 1992, PREV MAN UNS AB REP
[3]  
Cohen J, 2008, AIDS, V22, pS93, DOI 10.1097/01.aids.0000327440.59032.20
[4]  
Coliver Sandra, 1995, RIGHT KNOW HUMAN RIG, p[39, 61]
[6]  
Erdman J.N., 2011, HARV J L GENDER, V34, P413
[7]  
Ezard Nadine., 2001, International Journal of Drug Policy, V12, P207, DOI DOI 10.1016/S0955-3959(01)00093-7
[8]  
Freedman LP, 1995, RIGHT KNOW HUMAN RIG, p[1, 23]
[9]  
Hathaway A D., 2001, Int J Drug Policy, V12, P125, DOI 10.1016/S0955-3959(01)00085-8
[10]  
Inter-American Commission on Human Rights, 1999, OEASERLVII102 INT CO